Avg closing price
Price range

2 Julian Robertson Adaptive Biotechnologies Trades

Julian Robertson's position in Adaptive Biotechnologies is currently worth $6.61 Million. That's 2.18% of their equity portfolio (11th largest holding). Julian Robertson started to build up the position in Adaptive Biotechnologies in Q3 2019. Since then they sold 526 Thousand shares. The investor's estimated purchase price is $24.1 Million, resulting in a loss of 73%.

Avg closing price
Price range
Sold 47.2% shares (-526 Thousand shares) Q1 2022
Avg closing price $15.72
Price range $10.12 - $28.90
New holding (+1.12 Million shares) Q3 2019
Avg closing price $40.81
Price range $30.31 - $53.51

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!